Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RX-10100 in Erectile Dysfunction
NCT00693056Phase 2Completed
- Sponsor
- Rexahn Pharmaceuticals
- Start
- Jun 2008
- Primary completion
- Mar 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of clavulanic acid in erectile dysfunction (ED), sponsored by Rexahn Pharmaceuticals. Started Jun 2008; status: completed.
02
Drugs
clavulanic acid
03
Conditions
erectile dysfunction (ED)
Beyond the preview
Go deeper on NCT00693056.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00693056.